Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVAXEL: Bevacizumab and capecitabine with radiotherapy in rectal cancer
NCT01043484Phase 2Completed
- Sponsor
- Spanish Cooperative Group for Digestive Tumour Therapy
- Start
- Dec 2009
- Primary completion
- Jan 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in rectal cancer, sponsored by Spanish Cooperative Group for Digestive Tumour Therapy. Started Dec 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT01043484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01043484.